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"B
ig data" has the potential to support personalized or precision medicine through more complex riskprediction algorithms with more predictors. [1] [2] [3] These data can be used to accurately assess disease risk across subgroups with distinct characteristics or health profiles -including situations where a health profile represents only a fraction of the overall population.
Furthermore, compared with more commonly used clinical data or epidemiology studies, large population health surveys have the potential to generate predictive algorithms that are more patient-oriented, have the potential to perform better across socioeconomic groups, and can be used for both population and clinical purposes.
First, population health surveys emphasize sociodemographic profile and health behaviours. These patient-oriented risks are common for multiple chronic diseases. 4 Risks are all ascertained using self-response questions and validated for use in a broad community setting. This allows people to calculate their own risk in a nonclinical setting -reducing the burden on clinicians to collect and perform risk calculation. Second, algorithms developed using entire populations should be better calibrated (i.e., predictive risk closely approximating real or observed risk) and generalizable (i.e., better performing in a wide range of settings). As well, there are opportunities to recalibrate risk algorithms using population data that are not feasible with clinical data. 5, 6 Predictors included body mass index, hypertension, diabetes, and multiple behavioural, demographic and general health risk factors. The primary outcome was the first major cardiovascular event resulting in hospital admission or death. Death from a noncardiovascular cause was considered a competing risk.
more easily used for population planning. Examples of population uses include estimating the future incidence of cardiovascular disease events in populations and estimating the future burden of health behaviours (e.g., smoking, physical activity, alcohol and diet). 7, 8 A precision population health approach tailors preventive strategies for specific subgroups at risk. 9, 10 For example, subgroups with a low socioeconomic position typically have higher cardiovascular disease risk and may benefit from a wider range and more intensive interventions for effective prevention and health promotion. [11] [12] [13] We developed and validated a prognostic cardiovascular disease risk algorithm -the Cardiovascular Disease Population Risk Tool (CVDPoRT) -using routinely collected data from population health surveys. The CVDPoRT has 2 potential uses: patient-oriented, individual cardiovascular disease risk assessment in the community setting, including assessment by patients or their clinicians; and population cardiovascular disease risk assessment for planning and research, including the evaluation of preventive strategies.
9,10

Methods study design and participants
The CVDPoRT was derived and validated using population-based secondary data. There were 4 steps: Final model generation -combination of validation and derivation data to estimate the final application the CVDPoRT algorithm using the same model specification as the original derivation model.
•
Derivation of the application model -creation of a parsimonious model (fewer predictors) that maintains discriminative ability, calibration and overall model performance. The protocol for development and validation of the CVDPoRT was registered and published (ClinicalTrials.gov, no. NCT02267447).
14 We adhered to the protocol without deviation from the published analysis plan with 2 exceptions: only the 2007 Canadian Community Health Survey was used for validation (as opposed to both 2007 and 2009), and additional sensitivity testing and exploratory analyses were performed after algorithm development, as described in the "Statistical analysis" section. Here we report analyses of the primary study outcome described in the protocol.
Respondents were excluded if they were not eligible for Ontario's universal health insurance program, were pregnant, self-reported a prior history of heart disease or stroke, or were younger than 20 years at the time of survey administration.
Data sources
Predictors were ascertained using self-responses from the Canadian Community Health Surveys. The Canadian Community Health Survey uses a multistage stratified cluster design that represents about 98% of the Canadian population over the age of 12 years and attains an average response rate of 80.5%. 15 To ascertain cardiovascular disease events, we individually linked the survey respondents to 2 population-based databases: hospital-admission records from the Canadian Institute for Health Information Discharge Abstract Database, and deaths from the Office of the Registrar General of Ontario Vital Statistics Database. 16, 17 All cardiovascular disease events and deaths were coded as International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10) codes (or ICD-9 codes for deaths before 2003 and hospital discharges before 2002).
outcomes
The primary outcome of interest was 5-year incidence of a major cardiovascular disease event resulting in hospital admission or death from cardiovascular disease (diagnostic codes and criteria as presented in Appendix 1, available at www.cmaj.ca/lookup/suppl/ doi:10.1503/cmaj.170914/-/DC1). 16 Respondents were followed from the survey administration date until the earliest of the following: incident event, death due to causes other than cardiovascular disease (defined as a competing risk), loss to follow-up (defined as loss of health care eligibility) or end of study (Dec. 31, 2012).
statistical analysis
We followed guidelines by Harrell 18 and Steyerberg 19 in the development of our analysis plan, which was constructed before any model fitting or any descriptive analyses involving the exposureoutcome associations. Key considerations in our approach were full prespecification of the predictor variables, use of flexible functions for continuous predictors, and preservation of statistical properties through avoidance of data-driven variableselection procedures. Table 1 shows the 21 predictor variables that were identified, including 7 sociodemographic, 8 behavioural, 7, 8, 21 5 general health and chronic conditions, and 1 design variable. 9, 22 The model included interactions between age and smoking, alcohol, diet, physical activity, body mass index (BMI), diabetes and hypertension. Data cleaning, model specification and model estimation are presented in Appendix 2, available at www.cmaj.ca/lookup/ suppl/doi:10.1503/cmaj.170914/-/DC1. Models were estimated using a proportional hazards model for the subdistribution of a competing risk, with death from a noncardiovascular disease cause considered as a competing risk. 23 Performance in the derivation and validation cohorts was assessed using measures of discrimination (ability to differentiate between individuals with high and low risk), and calibration (agreement between predicted and observed risk).
9,24-26 Subgroups were examined using predefined criteria for clinically or policy relevant standards of calibration (< 20% difference between observed and predicted estimates for categories with prevalence higher than 5%). 7, 9 The CVDPoRT differs from existing cardiovascular disease algorithms in its use of the competing risk approach. To facilitate algorithm comparison and to examine the role of competing risks for cardiovascular disease prediction, we conducted sensitivity analyses in which we used a standard Cox model, but otherwise maintained all predictor specifications.
We used the step-down procedure described by Ambler and colleagues 27 to identify a parsimonious model for applications where parsimony may be more important than accuracy. This procedure involves deleting variables to a desired degree of accuracy based on contribution to model R 2 .
ethics approval
The use of data in this project was authorized under section 45 of Ontario's Personal Health Information Protection Act, which does not require review by a research ethics board.
Results
Participants
The combined derivation and validation cohort consisted of 104 219 respondents, 818 478 person-years follow-up, with 3709 cardiovascular disease events until Dec. 31, 2012 . The number of noncardiovascular disease deaths (events from competing risk) in the combined cohort was 2947 for men and 3390 for women (Figure 1 ). Pack-years of smoking had the most missing data (2.5% of the study population), with other health behaviours Excluded having less than 1% missing data ( Table 2) . A total of 2.7% of participants were lost to follow-up; 1.2% of participants were lost to follow-up in the validation data set.
Model specification and development
The predictors, along with their initial and final degrees of freedom are shown in Table 1 . Partial correlation plots are presented in Appendix 3, available at www.cmaj.ca/lookup/suppl/ doi:10.1503/cmaj.170914/-/DC1. The female and male full models had 48 degrees of freedom and 47 degrees of freedom, respectively, with 20 predictors (10 continuous) and 13 interaction terms ( Table 1 ). The final (reduced) model for females had 36 degrees of freedom with 12 predictors (6 continuous) and 9 interaction terms; the model for males had 37 degrees of freedom with 12 predictors (7 continuous) and 9 interaction terms ( Table 1 ). The complete model specifications, estimated coefficients and the survey questionnaire are available in Appendices 4 and 5, available at www.cmaj. ca/lookup/suppl/doi:10.1503/cmaj.170914/-/DC1, and at https:// github.com/Ottawa-mHealth/predictive-algorithms. Figures 2  and 3 show the predicted risk for median exposure compared with a reference for each predictor for females and males. An interactive relative risk plot is available at www.projectbiglife.ca, and shows the influence of age and exposure-outcome relations. There was close agreement between predicted and observed numbers of cardiovascular disease events within the overall population (5-year observed cumulative incidence function v. predicted risk in men: 0.28%; in women: 0.38%) ( Table 3) . Among men, the algorithm was well-calibrated in 110 of 111 predefined policy-relevant subgroups, with observed versus predicted risk being greater than the predefined difference of 20% only for people with no leisure time physical activity (0 metabolic equivalents of task [METs]) (Appendix 7, available at www. cmaj.ca/lookup/ suppl/doi:10.1503/cmaj.170914/-/DC1). Among women, the algorithm was well-calibrated in 96 of 97 predefined policy-relevant subgroups, with observed versus predicted risk being greater than the predefined difference of 20% only for the lowest level of sense of belonging (Appendix 6, available at www. cmaj.ca/ lookup/suppl/doi:10.1503/cmaj.170914/-/DC1). A sensitivity analysis, in which algorithms were generated using a Cox proportional hazards model without competing risks, found slightly improved calibration in several subgroups, particularly those at higher risk deciles and for people older than age 70 years, but differences did not reach significance and the models had similar discrimination (men: C statistic 0.84 v. 0.82; women: 0.87 v. 0.86) (Appendix 9, available at www.cmaj.ca/ lookup/suppl/doi:10.1503/cmaj.170914/-/DC1).
Model performance
Interpretation
The CVDPoRT was developed and validated using large population health surveys that are routinely collected and contain only selfreported risk factors. The CVDPoRT has a high discrimination and shows good calibration in a wide range of sociodemographic groups -including education, ethnicity, immigration status, area deprivation and social cohesion -despite omission of risk factors Table 2 such as lipid levels and measured blood pressure. We attribute the favourable performance of the CVDPoRT to greater model specification and complexity compared with other commonly used cardiovascular disease risk algorithms. The algorithm was developed for population and individual uses. For population uses, health surveys (which are available in more than 100 countries) can be used to predict the number of people who will develop cardiovascular disease. 7, 9 How risk varies across populations -whether risk is diffused or concentrated -is a cornerstone of modern population planning. 34 Multivariable predictive algorithms are the most robust approach to describe population risk, and their use improves the assessment of population strategies. 10 Although the World Health Organization and others currently measure burden of disease without including an equity perspective, 35 the inclusion of sociodemographic factors in the CVDPoRT allows a straightforward assessment of cardiovascular disease risk, burden and intervention effectiveness by socioeconomic status. 7, 8 For individual use, the CVDPoRT's discrimination is exceeded only by QRISK3 -an algorithm that was also developed using "big" data; however, QRISK3 used clinical data that focused on clinical measures (lipids, blood pressure and disease states). 36, 37 Clinicians and patients appear to favour health behaviour interventions over medications for patients at low and medium risk, 38 but existing cardiovascular risk algorithms seldom assess the role of health behaviours beyond smoking. 2, 39 This means that clinicians have difficulty communicating the degree to which health behaviours contribute to cardiovascular risk, as well as the potential benefit from behavioural interventions. 40, 41 The CVDPoRT allows patients to assess their risk outside the clinic setting with only self-reported measures -with predictive accuracy that is better than that assessed using the algorithms currently recommended in Canada for the clinical setting. 42 Complex algorithms with many predictors are not necessarily more burdensome to patients -rather the opposite if, for example, calculations can be performed with partial responses using adaptive questionnaires (see the CVDPoRT online calculator at www.project biglife.ca). The CVDPoRT predictors are centred, which allows patients to calculate their cardiovascular disease risk as each question is answered with unbiased calculations. The concept of assessing risk incrementally as more information is available is a central concept to clinical decision-making, and facilitated when algorithms are derived using big data, but has not yet been widely adopted in chronic disease predictive algorithms. 43, 44 Personalized risk communication follows personalized risk assessment with a range of cardiovascular disease risk measures such as heart age. 45 See Box 1 for an example of CVDPoRT for individual use.
5-year relative risk of cardiovascular event
The use of large, routinely collected population health surveys provides 2 perspectives that are relevant for precision medicine. First, large databases provide sufficient statistical power to develop and validate predictive algorithms with a larger set of risk factors and greater specification of those risks, which in turn generate distinct risk estimates for a wide range of health profiles or populations.
Second, the high discriminating ability of the CVDPoRT suggests that sociodemographic factors and health behaviours have an important role in precision medicine. For example, although smoking is included in most clinical cardiovascular disease risk algorithms, it is typically considered as a categorical measure (i.e., current, former or never smoker). This is despite the fact that smoking is the most important cardiovascular disease risk factor, there is a clear continuous dose-response relationship, there is clear attenuation of risk with age, and there are clear recommendations that continuous measures should not be categorized in predictive algorithms. 41, 46, 47 A concern with complex algorithms is the lack of improved discrimination in the overall population when predictors are added beyond 4 or 5 basic exposures. 48, 49 In precision medicine there is less emphasis on the overall population and more on the value of prediction "within" individuals (clinical uses) or subgroups (population uses). [50] [51] [52] [53] We emphasized calibration across subgroups as a measure of the CVDPoRT's value for precision medicine. 53, 54 Commonly, calibration is assessed across deciles of predictive risk. Large data allowed us to assess CVDPoRT calibration for more than 200 predefined, policy-relevant subgroups.
The CVDPoRT maintained very good calibration (191 of 205 subgroups) and was developed with few missing follow-up data, but we recommend recalibration of the CVDPoRT for most new settings. Fortunately, population-based data and health surveys provide opportunities to assess and recalibrate risk algorithms that are not available in the clinical setting. 7, 55 Surveys that are similar to the Canadian Community Health Survey are available in many countries worldwide. Increasingly, these surveys are being linked to health outcomes, enabling calibration assessment and, if required, recalibration. Additionally, unlinked cardiovascular disease events are even more available worldwide; these events can be compared with predicted cardiovascular disease events -calculated using the CVDPoRT and local population health surveysto enable recalibration to the local population. 5 The need for recalibration would not indicate that the CVDPoRT has poor predictive accuracy; rather, it would signal that factors beyond those included in the CVDPoRT are influencing baseline risk in the new population. Recalibration adjusts for these factors -conserving the purpose of the CVDPoRT to discriminate risk based on health behaviours (smoking, alcohol, diet and exercise). The statistic ranges from 0 to 1: a value of 0.5 indicates the model is no better than random prediction, a value of 1 indicates the model perfectly predicts those who will develop the outcome of interest and those who will not. Ratio of 95 to 5 risk percentiles is a test of discrimination. A higher ratio indicates a more discriminating algorithm. For example, a ratio of 100 indicates that the absolute risk is 100 times higher for a person in the 95th percentile than for a person in the 5th percentile. The ratio can be used to gauge the potential absolute benefit of treatment for different individuals in the development and validation cohorts. For an intervention with the same relative benefit, a risk ratio of 100 indicates that 1 person will have 100 times the absolute benefit of the comparative person. 2) Calibration reflects agreement between the observed outcomes and predictions. Calibration (or accuracy) describes how well the predicted probability of disease agrees with the observed outcome. Observed versus predicted (O v. P) is the relative difference between the observed incidence and predicted risk. A 1% difference in O v. P indicates 1% more cardiovascular events were observed than predicted. This 31 Nagelkerke R 2 is a measure of amount the model explains the variation of risk between respondents in the development or validation data with values from 0 to 1. 32, 33 Larger R 2 values indicate that more of the variation is explained by the model, to a maximum of 1.
Cardiovascular disease has predictors that span sociodemographic (e.g., ethnicity, social position, immigrant status), environmental (e.g., air pollution), distal (e.g., health behaviours), proximal (e.g., BMI, hypertension, lipids and other diseases) and genetic risks. To our knowledge, previous cardiovascular disease algorithms have not considered the full range of predictors or, more specifically, have not considered discriminating and wellcalibrated risk prediction for people exposed to those predictors. In the example of CVDPoRT and QRISK3 algorithms, there are several important differences in the predictors used, which suggests that a combined algorithm that considers the range of predictors and interactions from both algorithms could be even more discriminating and well-suited for precision medicine in clinical and population settings. Clearly, such an algorithm would require large data, suggesting there is a role for linking larger clinical and population data to provide a wider range of predictors that can be assessed. 2 That stated, it may be overly challenging to see improved discrimination beyond that shown in our study or QRISK studies, and calibration may not improve for subpopulations. In our study, we found that a more parsimonious CVDPoRT algorithm has essentially the same predictive ability as our fully prespecified algorithm.
limitations
A potential limitation is misclassification error resulting from use of self-reported predictors and routinely collected outcomes. Although more accurate risk factor ascertainment could improve discrimination and calibration, the CVDPoRT already has a high discrimination and favourable calibration. Other studies have also found that chronic diseases can be accurately assessed using selfreports, with only modest classification differences when cardiovascular risk assessment is performed with and without clinical and laboratory measures. 56, 57 conclusion The CVDPoRT discriminately assesses cardiovascular disease risk using information that focuses on sociodemographic and behavioural risks. For the clinical setting, the CVDPoRT can be completed by individuals in the community, without assistance of a clinician or use of clinical measures (e.g., cholesterol and blood pressure), to help inform subsequent clinical decisions. In the population setting, the CVDPoRT can assess cardiovascular disease risk using population health surveys that are available in many countries and settings.
